Clinical Trial Update: Hybrid Revascularisation by Combined Coronary Artery Bypass Graft (CABG) and PCI in Multivessel Coronary Disease

View source ↗

Summary

The clinical trial examining hybrid revascularization by combining CABG and PCI for multivessel coronary artery disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Ettore Sansavini Health Science Foundation | Conditions: Coronary Artery Disease (CAD) | Status: TERMINATED